Douglas Losordo
Overview
Douglas Losordo received an average of $589K in total compensation, including $201K in salary, at Cadrenal Therapeutics between 2022 and 2023. Douglas Losordo also received an average of $872K at Caladrius Biosciences from 2018 to 2020.
Source: SEC filings on June 11, 2024, April 28, 2021, and April 28, 2020.
Related executives
We found 12 more executives who work or worked at Cadrenal Therapeutics and Caladrius Biosciences.
David Mazzo
Caladrius Biosciences
Chief Executive Officer
David Slack
Caladrius Biosciences
Former President and Chief Business Officer
Kristen Buck
Caladrius Biosciences
Chief Medical Officer
Quang Pham
Cadrenal Therapeutics
Chief Executive Officer
Matthew Szot
Cadrenal Therapeutics
Chief Financial Officer
Todd Girolamo
Caladrius Biosciences
General Counsel
Joseph Talamo
Caladrius Biosciences
Chief Financial Officer
William Sietsema
Caladrius Biosciences